arrow
D

Davide Arillotta

university of hertfordshire medical school
H指数:15
被引数:723

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

GLP-1 and dual GIP/GLP-1 receptor agonists’ psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill–informed, systematic, evaluation

胰高血糖素样肽-1及其双重GIP/GLP-1受体激动剂的精神性药理学及潜在神经精神相关效应:一项基于Bradford Hill标准的系统评价

2026-08-210
OA
Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment

非那雄胺和多沙唑嗪相关的抑郁和自杀倾向信号检测:更新的药物警戒证据及全面的精神性评估建议

2026-04-060
OAAI
Possible Eye Disorders in Children Prenatally Exposed to Either Methadone or Buprenorphine in Comparison with Other Medications; An Examination of the Food and Drug Administration (FDA) Pharmacovigilance Database

孕期接触美沙酮或丁丙诺啡的儿童可能出现的眼部疾病与其他药物的对比研究;对食品药品监督管理局(FDA)药物警戒数据库的考察

2026-03-030
OAAI
Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis

探索减肥治疗中自杀念头,自我伤害和GLP-1受体激动剂之间的关联: 来自药物警戒措施和揭露分析的见解

2024-05-0113
OAAI